TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ABSI

Absci Corp

Healthcare · Biotechnology

9.70$ -5.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABSI
Line item 2019 2020 2021 2022 2023 2024 2025
– +354.9% +381.2% -24.7% -32.3% -1.7% +1.3%
– +436.6% +272.9% -31.6% -35.5% +11.0% +11.8%
– +433.9% +261.5% -76.3% +20.7% -43.0% -51.4%
– +433.9% +261.5% -34.9% -40.6% +15.1% +28.3%
– +618.0% -10.6% +8.8% +41.2% -100.0% –
– +0.0% +1,051,299,900.0% +42.9% – – –
– +167.2% +338.2% -1.0% – – –
– – – +0.0% -100.0% – –
– -33.6% +29,151.1% -6.1% -6.5% -7.0% -7.5%
– -64.4% +178.6% -22.5% -11.7% -16.2% -22.1%
– +191.3% +235.4% -10.6% -2.4% -3.1% -20.6%
– +100.4% +76.9% +3.7% -19.5% -20.8% -39.4%
– +689.6% +296.3% -71.2% -37.7% +134.8% -21.9%
– +137.2% -72.9% +610.3% -41.6% -73.0% –
– – +446.4% -25.0% -35.8% +1.7% +5.8%
– – – – – – –
– +0.0% +0.4% -1.9% +1.3% +19.8% +24.1%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?